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6INTRODUCTION
Spinal anaesthesia is induced by injecting small amounts of local 
anaesthetic into the cerebro-spinal fluid (CSF). The injection is usually 
made in the lumbar spine below the level at which the spinal cord ends. 
Spinal  anaesthesia is easy to perform and has the potential  to provide 
excellent  operating  conditions  for  surgery  below  the  umbilicus. 
Advantages include rapid onset, profound sensory and motor block, and 
lack of systemic effects, avoidance of tracheal intubation and a decreased 
need  for  opioid  administration.  Other  theoretical  benefits  include  the 
attenuation of the neuroendocrine response to surgical stress, facilitation 
of  rapid  tracheal  extubation  (for  combined  techniques),  improved 
ventilatory  mechanics,  and  decreased  post-anaesthesia  care  unit  and 
hospital stay.
Spinal anaesthesia is an excellent option in paediatric population as 
it  provides  a  rapid  onset  of  profound  and  predictable  uniformly 
distributed  analgesia  with  good  neuromuscular  blockade.  Spinal 
anaesthesia  has  traditionally  been  used  in  ex-premature  neonates  and 
infants<60 weeks post-conceptional age who are at an increased risk of 
post-operative  apnoea  due  to  bronchopulmonary  dysplasia  and 
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prematurity1,2. Spinal anaesthesia has also been used in older children to 
provide  intra-  and  post-operative  analgesia,  especially  for  procedures 
done as day-case surgery4. Paediatric spinal anaesthesia has proven to be 
a  safe  alternative  to  routinely  administered  general  anaesthesia  as  it 
avoids the polypharmacy associated with the latter  technique and also 
reduces  the  incidence  of  post-operative  respiratory  complications 
associated with administration of general anaesthesia2.
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8AIM OF THE STUDY
To compare two different doses- 0.3mg/kg and 0.5mg/kg- of 0.5% 
hyperbaric Bupivacaine given intrathecally in children aged 5-12 years 
undergoing  surgeries  of  the  lower  extremities  and  infra-umbilical 
procedures; in terms of duration of analgesia and incidence of intra- and 
post-operative complications.
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HISTORY OF PAEDIATRIC SPINAL ANAESTHESIA
Regional anaesthesia in children was first studied by August Bier 
in 1899. In 1900, Bainbridge reported a case of strangulated hernia repair 
under spinal anaesthesia in an infant aged three months. Thereafter, Tyrell 
Gray,  a  British  surgeon  published  a  series  of  200  cases  of  lower 
abdominal surgeries in infants and children under spinal anaesthesia in 
1909-1910. After some years it fell into disuse because of the introduction 
of  various  muscle  relaxants  and  inhalational  agents  and  was  almost 
unused after World War II. Despite scattered reports, it was not until a 
1984  study  by  Abajian  et  al1,  that  infant  spinal  anaesthesia  was 
successfully reintroduced to the modern era. 
Since that time, infant spinal anaesthesia has been used alone or in 
combination  with  epidural  anaesthesia  for  a  variety  of  surgical 
procedures,  including  inguinal  hernia  repair,  exploratory  laparotomy, 
repair  of  gastroschisis,  orthopaedic  procedures,  pyloromyotomy,  and 
meningomyelocele  repair  and  as  an  adjunct  to  general  anaesthesia  in 
infants  undergoing  repair  of  complex  congenital  heart  disease  with 
cardiopulmonary bypass.
9
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ANATOMY
The spinal cord usually ends at the level of L2 in adults and L3 in 
children9,10,15. Dural puncture above these levels is associated with a slight 
risk  of  damaging  the  spinal  cord  and  is  best  avoided.  An  important 
landmark to remember is that a line joining the top of the iliac crests is at  
L4 to L58,11. The following structures are pierced as the needle enters the 
CSF12.
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Skin. It is wise to inject a small bleb of local anaesthetic into the 
skin before inserting the spinal needle.
Subcutaneous fat. This  is  of  variable  thickness.  Identifying the 
intervertebral spaces is far easier in thin patients.
Supraspinous  ligament joins  the  tips  of  the  spinous  processes 
together.
The interspinous ligament is a thin flat band of ligament running 
between the spinous processes.
The  ligamentum flavum is  quite thick,  up to about 1cm in the 
middle and is mostly composed of elastic tissue. It runs vertically from 
lamina to lamina. When the needle is within the ligaments it  will feel 
gripped and a distinct "give" can often be felt as it passes through the 
ligament and into the epidural space.
The epidural space contains fat and blood vessels. If blood comes 
out of the spinal needle instead of CSF when the stylet is removed, it is 
likely that an epidural vein has been punctured. The needle should simply 
be advanced a little further.
The Dura. After feeling a "give" as the needle passes through the 
ligamentum flavum, a similar sensation may be felt when the needle is 
advanced a further short distance and pierces the Dural sac.
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The subarachnoid space. This contains the spinal cord and nerve 
roots surrounded by CSF. An injection of local anaesthetic will mix with 
the CSF and rapidly block the nerve roots with which it comes in contact.
Spinal anaesthesia is obtained by blocking the spinal nerves with 
drug  administered  into  the  sub-arachnoid  space,  below  the  level  of 
termination of the spinal cord.  The spinal cord ends at L3 level at birth 
and reaches L1 by 6-12 months. The Dural sac is at the S4 level at birth 
and reaches S2 by the end of the first year.
Sagittal view through the lumbar vertebrae and sacrum
The line joining the two superior iliac crests (inter-cristal /Tuffier’s 
line) crosses at L5-S1 interspace at birth, L5 vertebra in young children and 
L3-L4 interspace  in  adults10.  It  is  for  this  reason  that  lumbar  puncture 
should be performed at a level below which the cord ends, safest being at 
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or  below the  inter-cristal  line.  The distance  between  the  skin  and the 
subarachnoid space is influenced by age – from 10 to 15mm in newborns.
 The distance between skin and subarachnoid space can be related 
to height or weight using the formulae10,14:
Distance from skin to subarachnoid space (cm)= 0 03xheight (cm)
Distance from skin to subarachnoid space (mm) = (2 x weight) + 7
Depth of sub-arachnoid space from skin
Cerebrospinal  fluid  is  a  clear  body  fluid  that  occupies  the 
subarachnoid space and the ventricular  system of the brain and spinal 
cord. 
Cerebrospinal fluid volume at different periods of life10
Neonates - 10 ml/kg
Infants less than 15kg -  4 ml/kg
Young children - 3 ml/kg
Adolescent /Adult - 1.5 – 2 ml/kg
CSF Volume(ml/kg) changes with age
The volume of distribution of drugs injected into the subarachnoid 
space is higher in infants and neonates than in adults and consequently 
the injected dose is relatively greater in infants and neonates. The volume 
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of cerebrospinal fluid in the neonate is 4ml/kg, which is double the adult 
volume10,13. Moreover, in infants half of this volume is in the spinal space 
whereas adults  have only one-fourth.  The greater  volume of CSF and 
higher turnover account for the much shorter duration of subarachnoid 
block, with any given agent, as compared with adults.
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PHYSIOLOGIC RESPONSE TO SPINAL 
ANAESTHESIA
Local  anaesthetic  solution  injected  into  the  subarachnoid  space 
blocks conduction of impulses along all nerves with which it comes in 
contact, although some nerves are more easily blocked than others. There 
are three classes of nerve: motor, sensory and autonomic. Stimulation of 
the motor nerves causes muscles to contract and when they are blocked, 
muscle paralysis results. Sensory nerves transmit sensations such as touch 
and pain to the spinal cord and from there to the brain, whilst autonomic 
nerves control the calibre of blood vessels, heart rate, gut contraction and 
other functions not under conscious control12.
ERLANGER-GASSER CLASSIFICATION OF NERVE FIBRES12
Fibre 
Type Diameter Myelin Velocity Function
A-alpha 13-22 um + 70-120 
m/s
Motor, proprioception
A-beta 8-13um + 40-70 m/s Touch, kinesthesia
A-gamma 4-8um + 15-40 m/s Efferent to muscle 
spindle
A-delta 1-4um + 5-15 m/s Pain, pressure 
temperature
B 1-3um - 3-14 m/s Pre-ganglionic 
sympathetic
C 0.4-1.2um - 0.2-2.0 
m/s
Post-ganglionic, pain, 
touch, temperature
Generally, autonomic and sensory fibres are blocked before motor 
fibres.  This  has  several  important  consequences.  For  example, 
vasodilation and a drop in blood pressure may occur when the autonomic 
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fibres are blocked and the patient may be aware of pressure or movement 
and yet feel no pain when surgery starts.
DIFFERENTIAL BLOCKADE12
The lowest concentration of an anaesthetic agent that blocks the 
conduction of nerve impulses in a reasonable time is termed Cm or the 
minimal anaesthetic concentration. On the basis of differing Cm values of 
local anaesthetics for different nerve fibres, selective blockade of certain 
fibres  and  their  function  without  blockade  of  other  fibres  can  be 
accomplished.  This  is  called  differential  nerve  block.  In  the 
subarachnoid space, it appears that the B-fibres containing pre-ganglionic 
autonomic fibres are blocked quickly and by a Cm similar to that of small 
A-fibres.
Order of blockade following subarachnoid anaesthesia12:
Vasomotor
Cold temperature
Warmth
Slow pain
Fast pain
Motor
Joint sense / Proprioception
Pressure
Generally,  autonomic  blockade  is  2  dermatomes  cephalad  to 
sensory blockade, which is in turn 2 dermatomes cephalad to the level of 
motor blockade.
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Physiologic  effects  of  subarachnoid  anaesthesia include  the 
following:
1. Hypotension due to – vasomotor paralysis
- loss of skeletal muscle tone
- direct effect on medullary centres
- hypoxemia of medullary centres
- direct  suppression  of  cardio-
accelerator fibres
- adrenal paralysis 
2. Bradycardia 
3. Effect on respiratory muscles
- intercostal muscle paralysis with higher levels
- bronchial spasm with higher level due to predominant 
vagal activity
4. Gastro-intestinal function
- Promotes gastric peristalsis
5. Suppression of the endocrine stress response
17
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CARDIOVASCULAR SYSTEM
Cardiovascular  changes  related  to  subarachnoid  anaesthesia  are 
less common in children than in adults. This is attributed to the immature 
sympathetic nervous system in children less than 2 years of age. Also full 
maturity of the autonomic nervous system is not attained until 8-10 years 
of age. This obviates the need for volume loading prior to performing a 
subarachnoid block. In children under 5 years of age, minimal changes in 
heart  rate  and  blood  pressure  have  been  reported16.  Cardiovascular 
changes due to spinal block, if they occur, are short lasting and respond to 
a bolus of intravenous fluid (10ml/kg). Cardiovascular stability in infants 
undergoing  subarachnoid  anaesthesia  is  probably  related  to  smaller 
venous capacitance in the lower limbs leading to less blood pooling16, and 
to relative immaturity of the sympathetic nervous system resulting in less 
dependence on vasomotor tone to maintain blood pressure.
RESPIRATORY EFFECTS
Respiratory effects  of  SA are generally  seen in  association with 
high motor block above T6.  Children with severe chronic lung disease 
should  receive  supplemental  oxygen  or  Continuous  Positive  Airway 
Pressure (CPAP) during subarachnoid anaesthesia9,18.
The physiological impact of sympathectomy is minimal or none in 
smaller age groups. The fall in blood pressure and a drop in the heart rate 
are practically not seen in children less than five years. Therefore there is 
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no role of preloading with fluids before a subarachnoid block. This may 
be due to the immature sympathetic nervous system in children younger 
than  five–eight  years  as  a  result  of  the  relatively  small  intravascular 
volume in the lower extremities and splanchnic system limiting venous 
pooling  and  relatively  vasodilated  peripheral  blood  vessels.  Infants 
respond to high thoracic spinal anaesthesia by reflex withdrawal of vagal 
parasympathetic  tone to the heart.  It  is  one of the reasons why spinal 
anaesthesia has been the technique of choice in critically ill and moribund 
neonates who present for surgery in grave haemodynamic instability.
TESTING LEVEL OF BLOCKADE
1. Testing for sensory level12
a. Pinprick- 2 dermatomes cephalad to loss of touch
b. Cold stimulus-one dermatomal segment higher than pinprick
Sympathetic block extends three or more dermatomes above loss of 
pinprick  sensation.  Regression  from  the  time  of  onset  of  maximum 
analgesia  to  complete  disappearance  of  analgesia  is  to  be  observed, 
though intermediate times such as
a. Regression by two segments and
b. Regression to T10 or T12 appear to be more relevant.
2. Assessment of motor block12
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a. Sequence and onset of block:  Modified Bromage Scale 
(modified by Logan-Wildsmith)
Modified Bromage Scale
Scale Criteria Block degree
0 Free movement of legs and feet, with ability 
to raise extended leg
None
1 Inability  to  raise  extended  leg  and  knee 
flexion is decreased, but full flexion of feet 
and ankles
Partial,33%
2 Inability  to  raise  leg  or  knees,  flexion  of 
ankle and feet present
Partial,66%
3 Inability to raise leg, flex knee or ankle, or 
move toes
Complete
b. Recovery from motor blockade: Bromage Scale
Scale Degree of block Criteria
I Complete Unable to move feet or knees
II Almost complete Able to move feet only
III Partial Just able to flex knees
IV None Full flexion of knees and feet
3.Assessment of sympathetic blockade
a. Sympatho-galvanic reflex
b. Measuring skin temperature- rise in temperature 
below the level of block
POSITIONING FOR SPINAL ANAESTHESIA
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Subarachnoid anaesthesia in adults is performed in a position of 
universal flexion in either the sitting or lateral decubitus position12. One 
must ensure neutral position of the operating table, shoulders in a vertical 
plane and the presence of an assistant to hold and reassure the patient and 
also  to  ensure  that  the  patient’s  airway  is  free.  While  performing  the 
procedure  in  the  sitting  position,  the  assistant  holds  the  patient’s 
shoulders to prevent slouching.
Subarachnoid anaesthesia in children can be performed in either 
position.  In  older  children,  the  lateral  decubitus  position  is  preferred 
because it  provides better  control.  Distraction methods can be used to 
allay anxiety and an experienced anaesthesiologist is required to perform 
the technique quickly, gently and effectively. 
Subarachnoid  anaesthesia  in  neonates  and  infants19 can  be 
performed  in  either  the  sitting  or  lateral  decubitus  position.  The 
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anaesthesiologist performing the procedure should ensure that the airway 
is free and avoid extreme flexion of the neck as this tends to obstruct the 
airway.  One  must  also  observe  the  neonate’s  respiratory  pattern  and 
monitor oxygen saturation during the procedure.
NEEDLES FOR SUBARACHNOID ANAESTHESIA
Spinal needles are classified as12:
1. Dural-cutting - Quincke-Babcock needle
- Pitkin needle
2. Dural-splitting - Whitacre needle
- Sprotte needle
- Greene needle
SPINAL NEEDLES- 5 CM AND 7.5 CM
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These needles are available in different sizes ranging from 18G to 
30G. Also spinal needles are available in different lengths- 5cm, 7.5cm, 
9cm and 11cm. The shorter  needles,  when used in paediatric practice, 
allow easy insertion and also reduce the dead-space innate to the needle. 
An  average  9cm  spinal  needle  of  25G  has  a  dead-space  of  roughly 
0.06ml35.   This  will  result  in  less  than the calculated  volume of  drug 
reaching the subarachnoid space, especially of significance in paediatric 
spinal anaesthesia. 
The incidence of Post-Dural Puncture Headache (PDPH) initially 
thought to be negligent in infants and children has now been proven to be 
comparable to that in adults21-24. The apparent lower incidence arises from 
gross under-reporting of complaints and failure to recognize symptoms; 
although  no  difference  in  incidence  has  been  reported  between  dural-
cutting and dural-splitting needles of similar gauge.
23
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PHARMACOLOGY
The choice of local anaesthetic for subarachnoid administration is 
determined by the differences between adults and children with regard to 
pharmacology, physiology and appropriate dosing25; the most important 
difference is the increased risk of toxicity. Infants younger than 2 months 
are  particularly  at  risk  because  of  immature  hepatic  metabolism  and 
decreased  plasma  proteins  such  as  albumin  and  alpha-1-glycoprotein. 
This results in increased serum concentrations of the unbound amide local 
anaesthetics, especially bupivacaine and ropivacaine, which are normally 
90%  protein-bound.  Infants  also  have  decreased  levels  of  plasma 
pseudocholinesterase that theoretically could increase the risk of toxicity 
with ester local anaesthetics.
All children may be at increased risk of local anaesthetic toxicity 
because of the rapid increase in blood levels of local anaesthetic that may 
occur as a result of the relatively high cardiac output and regional blood 
flow that are present in this age group9.13.26.
Anaesthetic Plain(mg/kg) With epinephrine(mg/kg)
Lidocaine 7 5
Bupivacaine 3 3
Ropivacaine 3 3
Bupivacaine is a long-acting amide local anaesthetic marketed as a 
racemic mixture with a pKa of 8.1 and >95% protein binding. When given 
directly intravenous, bupivacaine saturates protein-binding sites on alpha-
1-glycoprotein  resulting  in  increased  free  fraction.  Bupivacaine  binds 
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avidly  to  cardiac  sodium-ion  channels,  strongly  and  constantly  even 
during diastole, causing greater cardiac toxicity than neurotoxicity. This is 
in  contrast  to  lignocaine  which  manifests  with  signs  of  neurotoxicity 
before cardiac symptoms.
CHEMICAL STRUCTURE OF BUPIVACAINE
SCHEMATIC STRUCTURE OF BUPIVACAINE
Bupivacaine  is  used  as  a  0.5%solution  for  subarachnoid 
anaesthesia made hyperbaric by the addition of 8% dextrose. The dose for 
subarachnoid  anaesthesia  in  adults  is  determined by the  height  of  the 
patient and the level of blockade required for surgery.
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On the contrary, in children the dose is determined by the weight of 
the child. A generally accepted weight-based dosing schedule is26:
Children weighing <5 kg : 0.5 mg/kg
Children weighing 5-15 kg : 0.4 mg/kg
Children weighing >15 kg : 0.3 mg/kg
Metabolism  of  bupivacaine  involves  hepatic  aromatic 
hydroxylation, N-dealkylation, amide hydrolysis and further metabolism 
by conjugation reactions to N-desbutylbupivacaine, which lacks intrinsic 
activity and is water- soluble to be eliminated by the kidneys. 
26
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requirement  and  provides  for  post-operative  analgesia.  Spinal 
anaesthesia is performed in the lateral decubitus position at a lower 
level: L4-L5 or L5-S1 . Incidence of PDPH is as high as in adults and is 
grossly under-reported.
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7. John  B.Rose,  Revista  Mexicana  de  Anestesiologia  Vol.27,  Supp.1 
2004.  Regional  anaesthesia  in  the  paediatric  age-group  is  to  be 
performed  after  sedation  because  it  provides  a  calm,  controllable 
child.
8. Hannu Kokki et al, Hyperbaric Buivacaine for spinal anaesthesia in 
7-18 yr old children: comparison of Bupivacaine 5mg/ml in 0.9% and 
8% glucose  solutions.  British  Journal  of  Anaesthesia  84(1):  59-62, 
2000. 107 children undergoing lower abdominal and lower extremity 
procedures  were  studied.  The  children  were  pre-loaded  with  5-10 
ml/kg  of  normal  saline.  Midazolam  0.5  mg/kg  was  used  as  oral 
premedication  45  minutes  prior  to  surgery.  Anticholinergic 
premedication  was  not  routinely  used.  EMLA  was  used  at 
venepuncture and lumbar puncture sites for topical anaesthesia. The 
average sensory level  with hyperbaric bupivacaine was T4,  average 
time to regression by 2-dermatomes was 85 minutes and time to first 
dose of rescue analgesic was 181 minutes (120-279min).
9. Bang-Vojdanovski B., 10 years of spinal anaesthesia in infants and 
children for Orthopaedic surgery; Anaesthetist. 1996 Mar; 45(3):271-7 
Children aged between 0-15 years were subjected to spinal anaesthesia 
using  hyperbaric  0.5%  bupivacaine  ranging  from  0.5-1.0  mg/kg. 
Haemodynamics were observed to be stable intra-operatively. Level of 
blockade was checked by pin-pricks and Bromage schema.
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10.Hannu  Kokki  et  al,  Post-dural  Puncture  headache  and  transient 
neurologic symptoms after spinal anaesthesia using cutting and pencil-
point paediatric spinal needles.  Acta Anaesthesiology Scandinavica, 
1998 Oct; 42(9): 1076-82. Children aged 2months to 10 years were 
given spinal  anaesthesia  comparing 25G Quincke needles  and 26G 
Atraucan needles versus 27G Whitacre and 24G Sprotte needles. They 
concluded that though the incidence of PDPH was comparable to that 
in adults, no difference was noticed between dural-cutting and dural-
splitting needles.
11.Lindo JO Rice,  John T.Britton;  Anaesthesiology Clinics of North 
America Volume 10,  Number  1:  129-142, March 1992. The author 
recommends the use of hyperbaric 0.5% bupivacaine at a dose of 0.5-
0.6mg/kg in older children up to 11 years of age.
12.Hannu  Kokki  et  al;  Spinal  anaesthesia  for  paediatric  day-case 
surgery:  a  double-blind,  randomised,  parallel  group,  prospective 
comparison of Isobaric and Hyperbaric Bupivacaine. British Journal 
of Anaesthesia 1998; 81: 502-506. Children aged 2-115 months were 
subjected  to  spinal  anaesthesia  following  a  premedication  of  0.5 
mg/kg  Diazepam.  EMLA cream  was  used  for  topical  anaesthesia. 
10ml/kg of normal saline was administered intravenously. The dose 
used was 0.3-0.4 mg/kg in children weighing more than 20kg. Their 
observed height of sensory blockade was T4 and time to 2-segment 
regression  was  80minutes.  Time  to  first  analgesic  rescue  was  110 
minutes (53-270) with hyperbaric bupivacaine.
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13.Elisabeth Giaufre, Bernard Dalens, Anne Gomdert; Epidemiology 
and  Morbidity  of  Regional  Anaesthesia  in  Children:  A One-year 
Prospective  Survey  of  the  French-Language  Society  of  Paediatric 
anaestheisologists, Anaesthesia & Analgesia 1996; 83:904-912. Spinal 
anaesthesia in the 3-12yr age-group using 0.5 mg/kg was less common 
than caudal anaesthesia in the same age-group. But the incidence of 
reported complications was very less. A 2/1000 morbidity in the form 
of intravascular injection was reported, though not associated with any 
clinical effects. 
14.Blaise G.A.; Spinal Anaesthesia in Children: Anaesthesia & Analgesia 
63: 227-230, 1984. Patients aged between 7weeks and 13 years were 
given  spinal  anaesthesia.  Hyperbaric  Bupivacaine  at  a  dose  of 
0.4mg/kg  was  used  providing  an  average  block  height  at  T7.  The 
children were preloaded with 6ml/kg of Ringer’s Lactate solution after 
an oral premedication of 0.1mg/kg two hours pre-operatively. Level of 
blockade was checked by bilateral pin-prick.
32
PILOT STUDY
The  study  was  undertaken  entirely  in  the  Department  of 
Anaesthesiology,  Government  Stanley  Medical  College  and  Hospital, 
Chennai during the period from February 2009 to July 2009 with due 
permission  from the  Institutional  Ethical  Committee  and  the  Head  of 
Department,  Paediatric  Surgery.  A Pilot  Study  was  first  conducted  to 
define the population and decide on the criteria for patient selection and 
exclusion, and the number of subjects required in each group.
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CRITERIA FOR PATIENT SELECTION
Children of either sex aged between 5 and 12 years belonging to 
ASA Physical Status I/II.
Exclusion Criteria include:
• Parental refusal
• Children  with  congenital  malformations  altering  the  surface 
anatomy
• Known coagulopathy
• Infection at the site of injection
• Generalised sepsis
• Children with known epileptic disorders or uncontrolled seizures
• Children known to have raised intracranial tension
• Children with a ventriculo-peritoneal shunt
Relative contraindication would be a child with an uncontrolled 
respiratory tract infection or an anticipated difficult airway.
The intended procedure was explained to the parents, all queries 
clarified and their due consent obtained.
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MATERIALS
Materials required for the study include:
• Spinal tray- comprising of
o  5cm 25g Quincke-Babcock 
o 9cm 25g Quincke-Babcock  needles for older children
o Sterile 2 ml syringe
o Sterile gauze
o Sponge-holding forceps
o Sterile drape
o Disinfectant solution
• Hyperbaric Bupivacaine 0.5% ampoules
• Midazolam for oral pre-medication
• Topical local anaesthetic cream Prilox
• Drugs for general anaesthesia in case of inadequate block
• Intravenous cannulae and I.V.fluids
• Emergency drugs
• Monitors- Pulse oximeter, Electrocardiogram, Non-invasive Blood 
Pressure 
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STUDY METHODS
The study was conducted as a Randomised controlled study with 
blinding of the patients. From the results obtained in the Pilot study, a 
target population of 30 subjects in each of the two groups- control and 
test was decided. After proper screening for the above-mentioned criteria, 
the  parents  were  informed  about  the  purpose  of  the  study  and  the 
procedure and intended study methods the day before surgery.  Parents 
were required to give their written consent on the morning of surgery.
 Selected children were randomly assigned to two groups- labelled 
as B1  and B2. Randomisation was achieved by allotting lot numbers; odd 
numbers were assigned to group B1 and even numbers to group B2. 
All children were fasted pre-operatively4,17,26,- 6hours for solids and 
2hours for clear fluids. Oral pre-medication of Midazolam30,34 at a dose of 
0.5mg/kg37 mixed  with  5-10ml   non-particulate  apple  juice  was 
administered to all children one hour before the procedure. At the time of 
pre-medication,  topical  local  anaesthetic  cream4,34 (Prilox-   Eutectic 
mixture of Local Anaesthetics: Lignocaine and Prilocaine) was applied to 
the site of intended lumbar puncture and potential sites of venepuncture 
and an occlusive dressing applied.
 Venous access was established with an appropriately sized cannula 
and  Ringer  lactate  solution-6ml/kg  infused5,7.  Standard  monitors  were 
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attached  and  baseline  values  of  heart  rate,  SpO2 and  blood  pressure- 
systolic and diastolic noted.
All measures for induction of general anaesthesia were kept ready. 
Keeping an eye on the saturation, the child was positioned in the lateral 
decubitus  position.  Ensuring  strict  asepsis,  lumbar  puncture  was 
performed in the L4/L5 or L3/L4 interspace by midline approach with the 
appropriate spinal needle. Intrathecal position was confirmed by the free 
flow of clear CSF. Hyperbaric Bupivacaine was loaded in a 2ml syringe 
prior  to  performing  lumbar  puncture-  children  belonging  to  group  B1 
receive  0.5mg/kg17,27,32,34 and  those  belonging  to  group  B2 receive 
0.3mg/kg26.  After  injection of  the  drug,  the  spinal  needle  was  kept  in 
position for up to 5 seconds to avoid tracking of drug4,5,27. On removal of 
the needle, the depth to subarachnoid space from skin level was noted on 
the shaft of the needle with a permanent marker pen.
In case of a bloody tap,  we waited for  the CSF to clear  before 
injecting drug or the needle was re-inserted in a different space. Three 
unsuccessful attempts was labelled a failed lumbar puncture. 
The child was positioned supine and the level of sensory blockade 
noted after 3minutes by looking for facial grimace and/or an increase in 
heart rate in response to pin-prick. Saturation, HR and blood pressure- 
systolic, diastolic and mean pressures- were noted at 5minute intervals for 
the first 15 minutes and every 15minutes thereafter.
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HYPOTENSION:  A fall  in  systolic  blood  pressure  >20%  from 
baseline was managed with a fluid bolus of up to 10ml/kg18,32.  Fall  in 
blood pressure that did not respond to fluids was treated with a dose of 
intravenous Ephedrine- 5mg.
BRADYCARDIA18,32:   Fall  in heart rate to less than 100bpm or 
>20%  from  baseline  (whichever  was  lower)  was  managed  with 
intravenous Atropine 0.02 mg/kg. 
APNOEA/DESATURATION: sustained respiratory pause of 15 sec 
or less than 15 sec if accompanied by oxygen saturation less than 90% or 
Bradycardia.
ECG changes, if any were noted- particularly an increase in T-wave 
amplitude10,26- suggestive of bupivacaine toxicity as might occur after an 
inadvertent intravascular injection.
Inadequate sensory blockade at the end of 5minutes was labelled a 
Failed Spinal and converted to general anaesthesia. All cases converted to 
General  anaesthesia  were  excluded  from  the  study.  An  apprehensive, 
restless child with an adequate block was managed by mask ventilation 
with nitrous oxide-oxygen mixture2,5,21,. Incidence of complications such 
as high spinal and intravascular injection was noted. At the end of the 
procedure, the duration of surgery was noted.
All children were observed for two hours after the end of procedure 
in the recovery room before being shifted to the post-op ward. Time to 2-
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segment  regression  by  checking  every  5  minutes  and  time  of  rescue 
analgesic administration, in the form of rectal Paracetamol (duration of 
analgesia)  were  noted.  Post-operative  complications  such  as  apnoea, 
nausea, vomiting and headache were looked for and treated accordingly. 
Also each patient was followed until discharge.
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STATISTICAL ANALYSIS
A sample size of 30 per group was decided during the pilot study. 
Randomisation  of  subjects  to  the  two  groups  was  done  by  allotting 
random numbers to each.  Children with odd numbers were allotted to 
Group B1 and those with even numbers were allotted to Group B2.
 Data  was  expressed  as  mean  +  SD.  Quantitative  analysis  was 
compared  with  student’s  t-test:  Equal-Variance  T-Test  Section  for 
comparison of discrete variables and the Aspin-Welch Unequal-Variance 
Test for continuous variables. 
When using the student’s t-test to compare the mean among the 
two groups, p-value of less than 0.05 was taken as significant.
The patients in each group were comparable in distribution in terms 
of age, weight and sex distribution.
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OBSERVATIONS AND RESULTS
DEMOGRAPHIC VARIABLES
TABLE - 1
AGE DISTRIBUTION AMONG GROUPS B1 AND B2
Group Mean 
(years)
Standard 
deviation
Standard 
Error
Student’s t-test
p value
B1 7.0333 1.916 0.3498221 0.529986
Not significantB2 7.35 1.965 0.3589176
 
BOX PLOT
4.00
6.00
8.00
10.00
12.00
B1
B2
Age distribution
Groups
Age
Both groups were  comparable  in  terms  of  age,  the  average  age 
being similar- around seven years in both groups.
TABLE - 2
GENDER DISTRIBUTION AMONG GROUPS B1 AND B2
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No significant difference was found among the two groups in terms 
of gender distribution. Among the 30 children in Group B1, 21 were boys 
and 9 were girls. In Group B2, 20 were boys and 10 were girls.
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TABLE - 3
WEIGHT DISTRIBUTION AMONG GROUPS B1 AND B2
Groups Mean 
weight (kg)
Standard 
deviation
Standard 
Error
Student t-test
B1 18.6333 4.589969 0.8380099 0.2229
Not significantB2 20.8666 3.892816 0.5980114
No significant difference among the two groups.
TABLE - 4
DURATION OF SURGERY AMONG GROUPS B1 AND B2
Groups Mean 
(minutes)
Standard 
Deviation
Standard 
Error
Student’s t-test
p-value
B1 27.83333 12.01173 2.193032 0.866433
Not significantB2 27.3333 10.88603 1.987509
BOX PLOT
10.00
25.00
40.00
55.00
70.00
B1
B2
Groups
Duration of surgery (min)
Duration of surgery was comparable between 
the two groups- roughly twenty-seven minutes in both groups.
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TABLE - 5
INTRA-OP HEART RATE VARIABILITY
INTRA-OP HEART RATE VARIABILITY
HR Mean
Standard 
Deviation
Standard 
Error
p-
value
B1 B2 B1 B2 B1 B2
Baselin
e 
99.266
6
97.8 8.9709 12.1411 1.6378 2.2166 0.5966
5 min 94.566
6
97.6333 9.8634 12.1413 1.8008 2.2166 0.2870
10 min 92.866
7
94.8 10.404 12.7884 1.8996 2.3348 0.5230
 15 min 92.533
3
94.4 8.5368 11.6784 1.5586 2.1321 0.4825
 30 min 91.2 91.8 8.4134 10.5680 1.5360 1.9294 0.8086
60 min 89.566
6
89.8333 8.3073 9.7912 1.5167 1.7876 0.9098
Comparison  of  heart  rate  measured  at  baseline,  5minute,  10 
minutes,  15  minutes,  30  minutes  and  60  minutes  after  administration 
showed  no  significant  differences  among  the  two  groups.  Clinically 
though, two children in Group B1  and one child in Group B2  developed 
significant  Bradycardia-  slowing  of  heart-rate  more  than  20%  from 
baseline, which responded to intravenous Atropine 0.02 mg/kg.
44
TABLE - 6
INTRA-OP SYSTOLIC BLOOD PRESSURE VARIABILITY
INTRA-OP SYSTOLIC BLOOD PRESSURE VARIABILITY
Systolic 
Blood 
Pressure
Mean Standard Deviation Standard Error p-valueB1 B2 B1 B2 B1 B2
Baseline 106.6 108.667 4.3990 5.2806 0.8031 0.9641 0.1051
5 min 104.433 105.667 5.5936 4.5435 1.0212 0.8295 0.1123
10 min 102.033
3
102.533 5.5116 4.7686 1.0062 0.8706 0.264
15 min 101.266
7
102.833 4.3938 3.6015 0.8022 0.6575 0.1363
30 min 101.9 102.7 2.9048 2.9378 0.5303 0.5363 0.293
60 min 102.867 102.133 2.9796 2.4876 0.5440 0.4541 0.305
Comparison of systolic blood pressures at baseline, 5 minutes, 10 
minutes, 15 minutes, 30 minutes and 60 minutes after administration of 
subarachnoid  block  showed  no  significant  difference  among  the  two 
groups, suggesting that there was no statistically or clinically significant 
fall  in  blood  pressure  associated  with  the  higher  dose  of  hyperbaric 
bupivacaine.
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TABLE - 7
INTRA-OP DIASTOLIC BLOOD PRESSURE VARIABILITY
INTRA-OP DIASTOLIC BLOOD PRESSURE VARIABILITY
Diastoli
c Blood 
Pressure
Mean Standard Deviation Standard Error p-value
B1 B2 B1 B2 B1 B2
Baseline 68.4333 70.4666 4.040 3.3603 0.7376 0.6135 0.06835
5 min 65 68 4.6756 4.1439 0.8536 0.7565 0.0109
10 min 62.5333 66.2 5.9465 4.5818 1.0856 0.8365 0.0096
15 min 61.8333 65.2333 4.7494 3.8746 0.8671 0.7074 0.0035
30 min 62.5 64.8333 3.8840 3.9135 0.7091 0.7145 0.024
60 min 63.1333 64.7 3.3086 3.8876 0.6040 0.7097 0.098
Diastolic blood pressure variability between the two groups was 
found to be significant from 5minutes to 30 minutes after administration 
of  subarachnoid  block.  More  specifically,  diastolic  pressures  were  4-
5mmHg  lower  among  Group  B1 subjects  receiving  0.5  mg/kg  of 
hyperbaric Bupivacaine. 
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TABLE - 8
LEVEL OF BLOCKADE- COMPARISON OF B1 AND B2
T5
T6
T7
T8
T9
B1
B2
Level of blockade
Groups
 Level of Blockade Group B1 Group B2
T5 2 0
T6 14 1
T7 10 11
T8 4 14
T9 0 4
             No children belonging to either group demonstrated a level 
higher than T5.  Children in Group B1 demonstrated consistently higher 
levels of sensory blockade- T6 on an average in group B1 versus T7-T8 in 
Group B2.
         0.0
3.8
7.5
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11.3
15.0
5.0
6.0
7.0
8.0
Histogram – Level of blockade Group B1
Level of blockade
Number 
0.0
3.8
7.5
11.3
15.0
6.0
7.0
8.0  
9.0
Histogram –Level of blockade GroupB2
Level of blockade
Number 
Statistical  analysis  by  the  Aspin-Welch  Unequal-Variance  Test 
showed high levels of significance with p-value of 0.0001.
48
TABLE - 9
SUPPLEMENTATION REQUIRED
Supplementation of
anaesthesia
Group B1 Group B2
Count Percent Count Percent
Required 3 10% 8 26.7%
Not required 27 90% 22 73.3%
Probability level- 0.0952
Though  not  found to  be  of  statistical  significance,  the  fact  that 
eight children receiving the conventional dose needed supplementation in 
the  form of  nitrous-oxide  oxygen mixture  by face-mask proves  to  be 
clinically  significant.  On  the  contrary,  only  3  children  in  group  B1 
required supplementation. 
Incidence  of  post-operative  complications  including  headache, 
apnoea/desaturation and post-op nausea/vomiting was not  significantly 
different. One child in each group developed vomiting after the surgery in 
the  post-op  recovery  room.  This  was  treated  with  intravenous 
Ondansetron 0.1 mg/kg. Both children were observed until the evening of 
surgery. There were no further episodes of nausea or vomiting.
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TABLE- 10
TIME TO 2-SEGMENT REGRESSION
20.00
45.00
70.00
95.00
120.00
B1
B2
2-segment regression
Groups
Group count Mean Standard deviation
Standard
Error
Student’s t-
test p-value
B1 30 91.5 12.32813 2.250798 0.00001,
SignificantB2 30 45.833
3
5.884423 1.074344
Time taken for the sensory level to regress by two segments was 
doubled in Group B1, compared to that in group B2. 
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TABLE - 11
TIME OF ANALGESIC RESCUE
160.0
195.0
230.0
265.0
300.0
-3.0
-1.5
0.0
1.5
3.0
Normal Probability Plot – analgesic rescue Group B1
Expected Normals
60.0
90.0
120.0
150.0
180.0
-3.0
-1.5
0.0
1.5
3.0
Normal Probability Plot - analgesic rescue Group B2
Expected Normals
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Group Count Mean
Standar
d 
deviation
Standar
d Error
Student t-test,p-
value
B1 30 213.3333 33.40796 6.099432 0.0001,
SignificantB2 30 127 28.66573 5.233623
Comparison  of  the  time  to  first  rescue  analgesic  after 
administration of subarachnoid block was prolonged in Group B1 versus 
Group B2. 
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DISCUSSION
Spinal  anaesthesia  can  safely  be  used  in  children  undergoing 
procedures in the lower abdomen and lower extremities. Our study used 
spinal anaesthesia for children undergoing the following procedures:
• Inguinal herniotomy : 19
• Circumcision : 18
• PV sac ligation for Hydrocele : 10
• Orchidopexy : 4
• Cystoscopy : 3
• Hypospadias repair : 1
• Lateral sphincterotomy : 1
• Miscellaneous : 4
Children belonging to Group B1 received 0.5mg/kg of Bupivacaine 
while children belonging to Group B2 received 0.3mg/kg of hyperbaric 
bupivacaine.  
The  average  age  in  the  two  groups  was  comparable-  around  7 
years.  The average  weight  in  both groups was also  comparable.  Both 
groups involved surgeries of similar duration- roughly 25 minutes.
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The procedure was performed with Midazolam sedation similar to 
that prescribed by G.A.Blaise and H.Kokki et al. Supplementation with 
nitrous oxide-oxygen was on the lines of that suggested by H.Kokki et al. 
Three children in group B1 required supplementation, and 5 in group B2 
required supplementation. None of the cases were converted to General 
anaesthesia. 
In  spite  of  the  widely  used  conventional  dose  of  0.3mg/kg  in 
children weighing over 15 kg, studies by Bang-Vojdanowsy33, Lindo JO 
Rice et al32 and E.Giaufre27,34 have used higher doses up to a maximum of 
1mg/kg  without  any  increase  in  the  incidence  of  haemodynamic 
instability or high spinal. This observation was made in our study also, 
where we used 0.5mg/kg of hyperbaric bupivacaine without an increased 
incidence  of  complications.  This  is  probably  attributed  to  the  larger 
volume per  kilogram body weight  of  CSF which allows for  a  greater 
volume  of  distribution  in  the  intrathecal  space.  Also  the  relative 
immaturity of the sympathetic nervous system prevents the occurrence of 
gross hypotension
 Pre-loading  was  not  used  by  Junkin  et  al36;  on  the  contrary, 
preloading with 5-10ml/kg of crystalloid was advocated by G.A.Blaise 
and H.Kokki. Neither study reported hypotension in the study age-group. 
In our study also,  there was no significant  fall  in systolic blood 
pressure which warranted active management. In our study, we observe a 
fall in diastolic blood pressure from 5minutes to 30 minutes after spinal. 
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This was managed with a fluid bolus of up to 10 ml/kg.  No children 
required vasopressors.
None of the previous studies reported significant Bradycardia. In 
our study, one patient belonging to group B2 had a significant decrease in 
heart rate which responded to intravenous Atropine. This was probably 
related  to  parasympathetic  overdrive  in  response  to  pain  due  to  an 
inadequate level of blockade.
H.Kokki et al have demonstrated an average level of blockade of 
T4 with 0.3 mg/kg, while our study showed an average of T7 with the 
lower dose and T5-T6 with the higher dose. This discrepancy is probably 
related to the method of checking for level of blockade. Kokki et al used 
Trans-cutaneous electrical stimulation to check the level.
Eight children in Group B2 required supplementation in the form of 
nitrous oxide-oxygen mixture by face mask, in comparison to only three 
children in Group B2.
Time  to  2-segment  regression  was  found  to  be  significantly 
different  in  our  study  among  the  two  groups.  Time  to  2-segment 
regression in earlier studies by Kokki et al, with 0.3 mg/kg, were around 
65-70 minutes.  Also the time to first rescue analgesic was longer. Group 
B2 children required rescue analgesic at around 120 minutes, comparable 
to the results obtained by H.Kokki et al  with the same dose.  Children 
receiving 0.5mg/kg required a rescue analgesic much later- 210 minutes.
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Post-operative  complications  such  as  apnoea,  desaturation  and 
headache  were  not  observed  in  our  study  in  either  group.  Post-op 
vomiting was seen in one child in each group which was managed with 
intravenous Ondansetron.
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SUMMARY
In  our  Randomised  controlled,  single-blind  trial  involving  30 
subjects in two groups; we compared the safety and efficacy of using a 
higher  dose  of  hyperbaric  bupivacaine  in  children  aged  between  5-12 
years.
Our observations include the following:
• Spinal anaesthesia is a safe technique for providing surgical 
anaesthesia in children.
• Spinal anaesthesia can be used as a stand-alone technique 
with minimal premedication in paediatric surgery, especially 
for day-case procedures.
• Pre-loading was not  required to prevent any fall  in blood 
pressure
• Haemodynamic stability is the rule in children younger than 
12 years.
• In  children  weighing  over  15  kg,  0.5mg/kg  can  be  used 
safely to provide a more predictable level of blockade and a 
longer  duration of  surgical  anaesthesia  and post-operative 
analgesia.
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CONCLUSION
Spinal  anaesthesia  was  demonstrated  to  be  a  safe  anaesthetic 
technique for paediatric surgery. The rapid onset and predictable motor 
blockade, with minimal requirement of supplemental anaesthesia prove to 
be advantageous in day-case surgeries in children.
A higher dose of Hyperbaric 0.5% Bupivacaine at 0.5mg/kg body 
weight is  found to be safe in children belonging to the 5-12 year age 
group  and  can  be  dependably  used  as  the  sole  anaesthetic  technique. 
There is no increased risk of complications. At the same time, the higher 
dose provides a more predictable height of sensory blockade and a longer 
duration  of  both  surgical  anaesthesia  and  post-operative  analgesia  in 
comparison to the conventional dose of 0.3mg/kg.
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PROFORMA
Name : Group assigned : B1 / B2
Age/Sex/Weight :
IP.Number :
Diagnosis :
Surgery planned :
ASA Status : Associated Medical conditions:
Last oral intake :
Oral Pre-medication-Diazepam 0.1mg/kg- Time:
Topical local anaesthetic cream         Time:
Shifted to theatre         Time:
Venous access secured         Time:
Monitors- baseline values:  HR -
           SpO2-
BP -
Positioning  :          Time:
Lumbar puncture : Number of attempts:
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Drug injected- Time :
Supine positioning :
Sensory level (response to pin-prick) :
Number of attempts :
Failed LP :
Failed Spinal :
Depth of insertion :
Intra-op complications
• Apnoea/ desaturation :
• Bradycardia :
• Hypotension :
• High spinal :
• Supplementation :
Duration of surgery :
Time to regression by 2-dermatomes:
Time to rescue analgesic:
Post-op complications
• Apnoea :
• Headache :
• PONV :
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DEMOGRAPHIC DATA- GROUP B1
S. 
No
Name Age Sex IP.No Surgery PS
Wt 
kg
Dose 
mg
Attempts
1. Swetha 5 F 11099 Cystoscopy I 16 8 1
2. Akash 5 M 10006 Circum I 15 7.5 1
3. Rajesh 10 M 10287 Orchidopex I 20 10 2
4. Sriram 6 M 11110 Circum I 14 7 1
5. Manoj 5 M 11003 PV sac lig I 15 7.5 1
6. Kamesh 6 M 10108 PV sac lig II 15 7.5 1
7. Dinesh 7 M 10312 Circum I 16 8 1
8. Ramya 5 F 10128 Herniotomy I 15 7.5 2
9. Nivedha 9 F 11113 Herniotomy II 22 11 1
10. Ranjith 6 M 11370 Circum I 18 9 2
11. Anwar 6.5 M 11184 Orchidopex I 20 10 1
12. Sairam 7 M 11090 Cystoscopy II 22 11 1
13. Varun 9 M 10356 PV sac lig I 26 13 1
14. Aswin 5 M 10285 PV sac lig I 12 6 1
15. Manish 5 M 12903 Hypospadias I 15 7.5 1
16. Ranjini 6 F 10374 Herniotomy I 16 8 1
17. Sanjay 11 M 10192 Circum I 28 14 1
18. Vikram 10 M 10023 Herniotomy II 30 15 1
19. Vineeta 6 F 12995 Herniotomy I 18 9 1
20. Mujibur 7 M 13890 Circum I 20 10 1
21. Rashmi 9 F 11002 Herniotomy I 20 10 1
22. Harish 6 M 10769 PV sac lig I 14 7 1
23. Murali 7 M 10273 Circum II 16 8 1
24. Padmini 11 F 10165 Herniotomy II 27 13 1
25. Priyank 7 F 10087 Lat. Sphinc II 20 10 1
26. Darsini 10 F 11747 Herniotomy II 24 12 1
27. Raghu 5 M 10118 Circum I 15 7.5 1
28. Niyatha 6 F 10092 Bursitis I 16 8 1
29. Pandian 7 M 12876 Circum I 16 8 1
30. Prabhu 6.5 M 10196 Ganglion I 18 9 1
GROUP B1- DATA
Sl. 
No
Heart Rate Depth Level
Sx
durn
Suppl
Faild 
LP
Faild 
spinl
bas 5m 10 15 30 60
1. 118 114 112 104 106 104 2.8 T7 20 N N N
2. 102 98 98 97 92 90 2.2 T6 20 N N N
3. 92 88 84 86 80 80 2.6 T6 65 N N N
4. 88 88 84 86 84 80 2.7 T8 20 N N N
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5. 110 115 116 102 98 98 2.2 T6 40 Y N N
6. 120 104 82 106 110 112 2.8 T8 35 N N N
7. 102 98 96 96 96 90 2.9 T7 20 N N N
8. 108 102 96 95 97 92 2.4 T6 30 N N N
9. 96 99 105 92 90 90 2.9 T7 40 Y N N
10. 106 72* 102 98 96 92 2.9 T6 15 N N N
11. 98 92 92 90 88 89 2.7 T7 40 N N N
12. 94 88 89 88 84 84 2.9 T6 25 N N N
13. 92 86 86 87 84 84 3.2 T6 30 N N N
14. 95 95 92 88 89 85 2.9 T7 35 N N N
15. 108 103 102 98 96 95 2.8 T6 45 N N N
16. 106 102 99 96 95 95 2.7 T7 25 N N N
17. 84 82 80 72 74 74 3.1 T8 15 N N N
18. 88 82 80 82 78 79 3.3 T6 35 N N N
19. 98 95 96 92 92 90 2.7 T6 40 N N N
20. 102 98 95 97 94 92 2.8 T7 15 N N N
21. 98 83 66* 112 102 100 2.8 T5 35 Y N N
22. 102 105 100 96 96 94 2.5 T6 20 N N N
23. 94 96 90 88 88 85 2.7 T7 15 N N N
24. 96 93 92 90 90 90 3.1 T5 40 N N N
25. 86 83 84 80 84 82 2.8 T6 15 N N N
26. 88 84 85 83 80 78 3.2 T6 25 N N N
27. 108 105 106 102 101 98 2.7 T7 15 N N N
28. 105 101 96 96 96 93 2.6 T8 25 N N N
29. 102 96 95 95 94 92 2.7 T6 15 N N N
30. 92 90 86 82 82 80 2.7 T7 20 N N N
*-  two  episodes  of  significant  Bradycardia-  responded  to  intravenous 
Atropine 0.02mg/kg.
GROUP B1- DATA
Sl.
No
Name
Systolic Blood Pressure Diastolic Blood Pressure
bas 5m 10m 15m 30m 60m bas
5
m
10
m
15
m
30
m
60
m
1. Swetha 100 100 90 90 100 102 60 60 60 60 60 58
2. Akash 107 102 98 99 100 104 62 65 60 59 62 63
3. Rajesh 112 110 104 106 103 106 69 67 60 62 64 62
4. Sriram 102 97 96 98 101 101 65 63 58 60 62 63
5. Manoj 104 107 97 96 98 100 66 64 56 55 55 59
6. Kamesh 103 96 94 98 100 102 65 54 50 57 59 60
7. Dinesh 109 104 103 100 101 103 68 62 62 60 62 64
8. Ramya 101 96 97 100 100 104 62 54 55 62 60 62
9. Nivedha 110 115 116 100 102 104 68 70 72 66 65 64
10. Ranjith 104 92 98 98 100 102 70 60 64 59 62 60
11. Anwar 105 102 100 100 100 101 68 60 62 58 60 65
12. Sairam 109 105 106 104 104 105 70 67 63 61 62 63
13. Varun 110 113 107 106 105 106 72 70 68 64 60 60
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14. Aswin 104 103 100 101 102 102 68 67 58 59 60 61
15. Manish 102 102 98 98 99 100 64 60 56 55 57 60
16. Ranjini 103 101 98 99 100 100 66 61 54 56 57 59
17. Sanjay 114 112 108 106 107 100 76 70 70 68 70 68
18. Vikram 120 116 112 114 110 112 80 74 78 74 72 70
19. Vineeta 105 104 101 99 104 104 68 66 62 60 67 68
20. Mujibur 108 108 108 105 105 103 68 68 66 63 67 68
21. Rashmi 110 107 102 100 102 106 70 69 65 68 66 68
22. Harish 102 100 100 99 98 103 70 63 63 60 60 59
23. Murali 107 105 108 104 103 97 68 68 66 60 62 64
24. Padmini 110 108 107 106 105 106 70 69 70 66 67 65
25. Priyanka 105 104 105 106 102 106 70 66 67 69 64 65
26. Darshini 112 110 106 106 107 103 69 71 69 72 68 68
27. Raghu 104 104 100 100 99 100 68 65 58 59 60 61
28. Niyatha 105 102 99 99 100 100 69 66 60 59 61 64
29. Pandian 107 104 102 100 100 101 66 66 62 60 62 60
30. Prabhu 104 104 100 101 99 100 67 65 62 64 62 63
GROUP B1- DATA
Sl. 
No
Name
Post-op complications 2-segment 
regression
Rescue 
analgesicPONV Apn/desat Headache
1. Swetha N N N 90 200
2. Akash N N N 70 220
3. Rajesh N N N 90 180
4. Sriram N N N 100 250
5. Manoj N N N 105 230
6. Kamesh N N N 95 165
7. Dinesh N N N 70 170
8. Ramya N N N 75 190
9. Nivedha N N N 85 225
10. Ranjith N N N 75 250
11. Anwar N N N 80 230
12. Sairam N N N 95 240
13. Varun N N N 90 175
14. Aswin N N N 85 205
15. Manish N N N 80 180
16. Ranjini N  N N 90 200
17. Sanjay N N N 110 285
18. Vikram N N N 120 280
19. Vineetha N N N 110 265
20. Mujibur N N N 90 240
21. Rashmi Y N N 110 240
22. Harish N N N 95 210
23. Murali N N N 90 195
24. Padmini N N N 105 225
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25. Priyanka N N  N 90 190
26. Darshini N  N N 100 240
27. Raghu N N N 85 175
28. Niyatha N N N 90 190
29. Pandian N N N 80 170
30. Prabhu N N N 95 190
DEMOGRAPHIC DATA- GROUP B2
S. 
No
Name Ag Sex IP.No Surgery PS
Wt 
kg
Dose 
mg
Attempts
1. Praveen 11 M 11019 Circum II 25 7.5 1
2. Sidharth 8 M 10238 Circum I 18 5.5 1
3. Barath 9 M 12364 Orchidopex II 25 7.5 1
4. Mahmud 6 M 10028 PV sac lig I 21 6 1
5. Rajkumr 5 M 10001 Herniotomy I 15 4.5 1
6. Prasanna 7 M 10108 Circum I 22 6.5 2
7. Ajay 6.5 M 16398 Circum I 24 7 1
8. Saifulla 8 M 17730 Herniotomy II 25 7.5 1
9. Lavanya 6 F 16029 FB foot I 20 6 1
10. Iswarya 7 F 12710 Herniotomy I 24 7 1
11. Gayatri 8 F 12681 Exostosis I 22 6.5 1
12. Harsha 7 M 17610 Circum I 22 6.5 1
13. Preetha 6 F 10781 Herniotomy I 20 6 1
14. Raghav 5 M 19800 Orchidopex II 17 5 1
15. Aruna 6 F 10988 Herniotomy II 18 5.5 1
16. Arjun 5.5 M 17812 PV sac lig I 16 5 1
17. Saktivel 6 M 19892 Circum I 17 5 1
18. Nizam 9 M 12673 PV sac leg I 26 8 1
19. Victor 5 M 12675 Herniotomy I 16 5 1
20. Akshay 10 M 12928 Circum II 26 8 1
21. Keziya 11 F 11673 Herniotomy I 22 6.5 2
22. Stephen 10 M 15142 Circum I 21 6 1
23. Anu 8 F 11283 Herniotomy I 23 7 1
24. Kavitha 6.5 F 09373 Herniotomy I 18 5.5 1
25. Jayanth 6 M 10193 PV sac lig I 16 5 1
26. Prem 5 M 14748 PV sac leg I 14 4 1
27. Gautam 7 M 13I33 Herniotomy I 18 5.5 1
28. Pradeep 11 M 11335 Cystoscopy I 27 8 1
29. Kavya 10 F 13162 ing node Bx I 28 8.5 1
30. Madhav 5 M 12135 Circum I 20 6 1
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GROUP B2- DATA
Sl. 
No
Heart Rate Depth Level
Sx 
durn
Suppl
Faild 
LP
Faild 
Spinl
bas 5m 10 15 30 60
1. 92 96 90 88 88 84 3.3  T8 15 N N N
2. 82 88 87 84 80 80 2.9 T7 25 Y N N
3. 102 92 64* 112 102 96 3.1 T8 30 Y N N
4. 92 95 99 102 93 93 2.8 T7 35 Y N N
5. 110 116 114 111 106 107 2.7 T7 45 Y N N
6. 106 100 96 97 99 93 2.8 T7 15 N N N
7. 102 96 93 92 92 91 2.9 T7 25 N N N
8. 78 76 69 74 74 76 3.0 T8 35 N N N
9. 96 92 93 96 94 90 2.8 T6 30 N N N
10. 102 100 95 94 90 88 2.8 T7 40 N N N
11. 92 92 94 90 90 90 3.2 T8 20 N N N
12. 88 88 86 78 83 84 2.9 T9 15 N N N
13. 98 99 95 94 92 89 2.8 T8 35 N N N
14. 109 114 107 99 101 100 2.7 T7 35 N N N
15. 115 118 109 104 100 99 2.9 T8 40 N N N
16. 122 126 117 114 110 107 2.7 T9 20 N N N
17. 109 104 104 99 95 96 2.8 T8 15 N N N
18. 78 76 79 73 72 72 3.2 T8 25 N N N
19. 109 102 110 106 101 100 2.7 T7 45 Y N N
20. 84 83 84 82 78 76 3.2 T7 15 N N N
21. 92 96 99 104 90 92 3.2 T7 30 Y N N
22. 88 90 85 85 80 80 3.0 T9 10 N N N
23. 96 95 95 100 104 90 2.9 T8 45 Y N N
24. 103 100 102 96 96 90 2.7 T9 40 N N N
25. 100 99 102 96 96 90 2.7 T8 20 N N N
26. 119 115 116 112 108 103 2.4 T7 25 N N N
27. 99 102 94 92 90 90 2.7 T8 40 Y N N
28. 78 80 82 73 71 70 3.1 T8 20 N N N
29. 84 89 82 83 80 78 3.0 T8 15 N N N
30. 109 110 102 99 97 100 2.7 T8 15 N N N
*- one child demonstrated an episode of Bradycardia, which was treated 
with intravenous Atropine- 0.02 mg/kg.
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GROUP B2- DATA 
Sl. 
No
Name
Systolic Blood Pressure Diastolic Blood Pressure
bas 5m 10m 15m 30m 60m Bas 5m 10m
15
m
30
m
60
m
1. Praveen 110 108 103 104 103 100 70 70 66 67 67 65
2. Sidharth 110 104 102 103 103 100 70 72 68 65 62 69
3. Barath 109 104 96 100 102 103 70 68 63 67 64 65
4. Mahmud 106 105 110 104 104 104 68 70 70 65 64 62
5. Rajkumr 104 105 103 100 100 100 69 69 66 67 62 63
6. Prasanna 107 106 102 100 100 102 69 69 66 65 64 65
7. Ajay 106 102 102 102 100 100 70 64 64 65 66 62
8. Saifulla 110 108 106 103 100 102 70 69 72 68 66 64
9. Lavanya 107 102 102 100 100 100 70 68 67 64 62 65
10. Iswarya 109 106 103 103 103 100 74 70 68 68 65 64
11. Gayatri 108 104 100 105 106 105 70 68 66 67 68 68
12. Harsha 105 105 103 100 102 105 69 66 64 65 66 66
13. Preetha 104 104 102 100 102 102 69 64 60 60 61 63
14. Raghav 100 101 96 95 98 102 66 62 61 57 60 60
15. Aruna 104 102 100 101 100 100 69 65 60 60 58 57
16. Arjun 100 95 94 98 101 100 63 60 58 61 68 66
17. Saktivel 104 104 100 100 101 100 69 66 62 63 64 60
18. Nizam 117 112 110 104 106 102 78 71 70 67 70 68
19. Victor 107 104 102 101 100 101 70 72 69 68 67 68
20. Akshay 114 109 110 110 105 105 70 68 68 66 67 68
21. Keziya 112 110 110 105 106 102 70 68 66 62 64 61
22. Stephen 119 112 108 105 106 104 78 75 78 70 72 70
23. Anu 120 117 114 110 112 109 78 78 71 74 70 70
24. Kavitha 110 106 104 105 106 106 71 72 70 74 72 73
25. Jayanth 105 100 100 101 102 99 68 60 58 61 59 59
26. Prem 109 104 100 101 100 99 69 61 60 62 61 60
27. Gautam 104 105 102 102 101 100 68 67 66 62 60 63
28. Pradeep 118 114 110 111 105 106 76 71 70 72 70 68
29. Kavya 116 111 109 108 105 104 72 70 70 66 67 69
30. Madhav 106 101 103 104 102 102 71 67 69 61 59 60
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GROUP B2- DATA
Sl. 
No
Name Post-op Complications
2-segment 
regression
Rescue 
Analgesic
PONV Apn/desat Headache
1. Praveen N N N 45 180
2. Sidharth N N N 40 140
3. Barath N N N 50 130
4. Mahmud N N N 45 110
5. Rajkumr N N N 45 90
6. Prasanna N N N 50 165
7. Ajay N N N 45 135
8. Saifulla N N N 50 120
9. Lavanya N N N 40 110
10. Iswarya N N N 35 85
11. Gayatri N N N 50 160
12. Harsha N N N 55 180
13. Preetha N N N 40 105
14. Raghav N N N 55 100
15. Aruna N N N 45 75
16. Arjun N N N 40 120
17. Saktivel N N N 50 160
18. Nizam N N N 55 150
19. Victor N N N 40 100
20. Akshay N N N 55 120
21. Keziya Y N N 40 70
22. Stephen N N N 45 120
23. Anu N N N 50 120
24. Kavitha N N N 40 140
25. Jayanth N N N 45 135
26. Prem N N N 40 130
27. Gautam N N N 40 120
28. Pradeep N N N 55 150
29. Kavya N N N 50 155
30. Madhav N N N 40 130
KEY TO MASTER CHART
PS - American Society of Anaesthesiologists 
Physical Status
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IP.NO. - In-patient number
Wt kg - Weight in kilos
bas - Baseline value
Depth - Depth of lumbar puncture
Level - Level of sensory blockade
Sx durn - Duration of surgery
Suppl - Supplementation of anaesthesia
Faild LP - Failed lumbar puncture
Faild spinal - Failed spinal blockade
PONV - Post-operative nausea/vomiting
Apn/desat - Apnoea/desaturation
2-segment regression - Time to regression by 2 segments
Rescue analgesic - Time of analgesic rescue
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